Home/TECregen/Dr. Klaas P. Zuideveld

DK

Dr. Klaas P. Zuideveld

Chief Executive Officer

Therapeutic Areas

Immunosenescence Oncology Supportive Care Immunodeficiency

TECregen Pipeline

Drug	Indication	Phase
Thymopoietic Platform	Immune reconstitution in aging, cancer, immune-compromised settings	Pre-clinical

Leadership Team at TECregen

Prof. Dr. Georg Holländer

Founder, Advisor, Head of Innovation

Filippo Oliveri

Founder, Head of Operations

Dr. Ignacio Moraga

Founder, Chief Scientific Officer

Dr. Bo Rode Hansen

Chairman of the Board

View full TECregen profile